Initial observations from clinical retinoblastoma pathological sections revealed a consistent expression trend, wherein the levels of ATF4 and ARL5B were both lower in normal para-cancerous retinal tissues compared to RB tumor tissues. The gene discussed is ARL5B; the disease is retinoblastoma.